Treatment of chronic plantar fasciopathy with extracorporeal shock waves (review)

Journal of Orthopaedic Surgery and Research

John P Furia¹  Humberto Chaves³  Jan-Dirk Rompe²  Nikolaus BM Császár⁴  Christoph Schmitz⁴ 

[1] Sun Orthopaedic Group, Inc., 900 Buffalo Rd., Lewisburg, PA, 17837, USA;OrthoTrauma Evaluation Center, Oppenheimer Str. 70, Mainz, 55130, Germany;Institute of Mechanics and Fluid Dynamics, TU Bergakademie Freiberg, Lampadiusstr. 4, Freiberg, 09596, Germany;Department of Anatomy II, Ludwig-Maximilians-University of Munich, Pettenkoferstr. 11, Munich, 80336, Germany

关键词: Plantar fasciopathy;    Plantar fasciitis;    Radial extracorporeal shock wave treatment (RSWT);    Extracorporeal shock wave treatment (ESWT);   

Others  :  814410
DOI  :  10.1186/1749-799X-8-31

 received in 2013-06-26, accepted in 2013-08-27,  发布年份 2013

【 摘 要 】

There is an increasing interest by doctors and patients in extracorporeal shock wave therapy (ESWT) for chronic plantar fasciopathy (PF), particularly in second generation radial extracorporeal shock wave therapy (RSWT). The present review aims at serving this interest by providing a comprehensive overview on physical and medical definitions of shock waves and a detailed assessment of the quality and significance of the randomized clinical trials published on ESWT and RSWT as it is used to treat chronic PF. Both ESWT and RSWT are safe, effective, and technically easy treatments for chronic PF. The main advantages of RSWT over ESWT are the lack of need for any anesthesia during the treatment and the demonstrated long-term treatment success (demonstrated at both 6 and 12 months after the first treatment using RSWT, compared to follow-up intervals of no more than 12 weeks after the first treatment using ESWT). In recent years, a greater understanding of the clinical outcomes in ESWT and RSWT for chronic PF has arisen in relationship not only in the design of studies, but also in procedure, energy level, and shock wave propagation. Either procedure should be considered for patients 18 years of age or older with chronic PF prior to surgical intervention.

【 授权许可】

   
2013 Schmitz et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

【 参考文献 】

• [1]Rompe JD: Plantar fasciopathy. Sports Med Arthrosc 2009, 17:100-104.
• [2]Thomas JL, Christensen JC, Kravitz SR, Mendicino RW, Schuberth JM, Vanore JV, Weil LS Sr, Zlotoff HJ, Bouché R, Baker J, American College of Foot and Ankle Surgeons heel pain committee: The diagnosis and treatment of heel pain. a clinical practice guideline-revision 2010. J Foot Ankle Surg 2010, 49:S1-S19.
• [3]Tong KB, Furia J: Economic burden of plantar fasciitis treatment in the United States. Am J Orthop 2010, 39:227-231.
• [4]Furia JP, Rompe JD: Extracorporeal shock wave therapy in the treatment of chronic plantar fasciitis and Achilles tendinopathy. Curr Opin Orthop 2007, 18:102-111.
• [5]Rompe JD, Furia J, Weil L, Maffulli N: Shock wave therapy for chronic plantar fasciopathy. Br Med Bull 2007, 81–82:183-208.
• [6]Neufeld SK, Cerrato R: Plantar fasciitis: evaluation and treatment. J Am Acad Orthop Surg 2008, 16:338-346.
• [7]Chow IH, Cheing GL: Comparison of different energy densities of extracorporeal shock wave therapy (ESWT) for the management of chronic heel pain. Clin Rehabil 2007, 21:131-141.
• [8]Gerdesmeyer L, Frey C, Vester J, Maier M, Weil L Jr, Weil L Sr, Russlies M, Stienstra J, Scurran B, Fedder K, Diehl P, Lohrer H, Henne M, Gollwitzer H: Radial extracorporeal shock wave therapy is safe and effective in the treatment of chronic recalcitrant plantar fasciitis: results of a confirmatory randomized placebo-controlled multicenter study. Am J Sports Med 2008, 36:2100-2109.
• [9]Marks W, Jackiewicz A, Witkowski Z, Kot J, Deja W, Lasek J: Extracorporeal shock-wave therapy (ESWT) with a new-generation pneumatic device in the treatment of heel pain: a double blind randomised controlled trial. Acta Orthop Belg 2008, 74:98-101.
• [10]Greve JM, Grecco MV, Santos-Silva PR: Comparison of radial shockwaves and conventional physiotherapy for treating plantar fasciitis. Clinics 2009, 64:97-103.
• [11]Ibrahim MI, Donatelli RA, Schmitz C, Hellman MA, Buxbaum F: Chronic plantar fasciitis treated with two sessions of radial extracorporeal shock wave therapy. Foot Ankle Int 2010, 31:391-397.
• [12]Dizon JN, Gonzalez-Suarez C, Zamora MT, Gambito ED: Effectiveness of extracorporeal shock wave therapy in chronic plantar fasciitis: a meta-analysis. Am J Phys Med Rehabil 2013, 92:606-620.
• [13]Ueberle F: Shock wave technology. In Extracorporeal Shock Waves in Orthopaedics. 1st edition. Edited by Siebert W, Buch M. Berlin: Springer; 1998:59-87.
• [14]Ueberle F: Einsatz von Stoßwellen in der medizin [Application of shock waves in medicine]. In Medizintechnik. 1st edition. Edited by Kramme R. Berlin: Springer; 2007:483-513.
• [15]Ogden JA, Tóth-Kischkat A, Schultheiss R: Principles of shock wave therapy. Clin Orthop Rel Res 2001, 387:8-17.
• [16]Schleberger R, Delius M, Dahmen GP, Diesch R, Schaden W, Thiele R, Vogel J: Orthopaedic extracorporeal shock wave therapy (ESWT): method analysis and suggestion of a prospective study design - consensus report. In High Energy Shock Waves in Medicine. 1st edition. Edited by Chaussy C, Eisenberger F, Jocham D, Wilbert D. Stuttgart: Thieme; 1997:108-111.
• [17]Rassweiler JJ, Knoll T, Köhrmann KU, McAteer JA, Lingeman JE, Cleveland RO, Bailey MR, Chaussy C: Shock wave technology and application: an update. Eur Urol 2011, 59:784-796.
• [18]Zhong P, Preminger GM: Mechanisms of differing stone fragility in extracorporeal shockwave lithotripsy. J Endourol 1994, 8:263-268.
• [19]Gerdesmeyer L, Weil LS: Extracorporeal Shock Wave Therapy: Technologies, Basics, Clinical Results. 1st edition. Data Trace Media: Brooklandville; 2007.
• [20]Csaszar NBM, Schmitz C: Extracorporeal shock wave therapy in musculoskeletal disorders. J Orthop Surg Res 2013, 8(1):22. BioMed Central Full Text
• [21]Gerdesmeyer L, Maier M, Haake M, Schmitz C: Physikalisch-technische Grundlagen der extrakorporalen Stosswellentherapie (ESWT) [Physical-technical principles of extracorporeal shockwave therapy (ESWT)]. Orthopade 2002, 31:610-617.
• [22]Chitnis PV, Cleveland RO: Acoustic and cavitation fields of shock wave therapy devices. In Therapeutic Ultrasound: 5th International Symposium on Therapeutic Ultrasound (AIP Conference Proceedings Vol. 829): October 27-29 2005, Boston. 1st edition. Edited by Clement GT, McDannold NJ, Hynynen K. College Park: American Institute of Physics; 2006:440-444.
• [23]Cleveland RO, Chitnis PV, McClure SR: Acoustic field of a ballistic shock wave therapy device. Ultrasound Med Biol 2007, 33:1327-1335.
• [24]Chalmers TC, Smith H Jr, Blackburn B: A method for assessing the quality of a randomized control trial. Control Clin Trials 1981, 2:31-49.
• [25]Jadad AR, Moore RA, Carrol D: Assessing the quality of reports of randomised clinical trials: is blinding necessary? Control Clin Trials 1996, 17:1-12.
• [26]Haake M, Buch M, Schoellner C, Goebel F, Vogel M, Mueller I, Hausdorf J, Zamzow K, Schade-Brittinger C, Mueller HH: Extracorporeal shock wave therapy for plantar fasciitis: randomised controlled multicentre trial. Brit Med J 2003, 357:75.
• [27]Kudo P, Dainty K, Clarfield M, Coughlin L, Lavoie P, Lebrun C: Randomized placebo-controlled double-blind clinical trial evaluating the treatment of plantar fasciitis with an extracoporeal shockwave therapy (ESWT) device: a North American confirmatory study. J Orthop Res 2006, 24:115-123.
• [28]Malay DS, Pressman MM, Assili A, Kline JT, York S, Buren B, Heyman ER, Borowsky P, LeMay C: Extracorporeal shockwave therapy versus placebo for the treatment of chronic proximal plantar fasciitis: results of a randomized placebo-controlled double-blinded multicenter intervention trial. J Foot Ankle Surg 2006, 45:196-210.
• [29]Buchbinder R, Ptasznik R, Gordon J, Buchanan J, Prabaharan V, Forbes A: Ultrasound-guided extracorporeal shock wave therapy for plantar fasciitis: a randomized controlled trial. J Am Med Assoc 2002, 288:1364-1372.
• [30]Gollwitzer H, Diehl P, von Korff A, Rahlfs VW, Gerdesmeyer L: Extracorporeal shock wave therapy for chronic painful heel syndrome: a prospective double blind randomized trial assessing the efficacy of a new electromagnetic shock wave device. J Foot Ankle Surg 2007, 46:348-357.
• [31]Blobaum P: Physiotherapy evidence database (PEDro). J Med Libr Assoc 2006, 94:477-478.
• [32]Rompe JD, Meurer A, Nafe B, Hofmann A, Gerdesmeyer L: Repetitive low-energy shock wave application without local anesthesia is more efficient than repetitive low-energy shock wave application with local anesthesia in the treatment of chronic plantar fasciitis. J Orthop Res 2005, 23:931-941.
• [33]Maier M, Averbeck B, Milz S, Refior HJ, Schmitz C: Substance P and prostaglandin E2 release after shock wave application to the rabbit femur. Clin Orthop Relat Res 2003, 406:237-245.
• [34]Hausdorf J, Lemmens MA, Kaplan S, Marangoz C, Milz S, Odaci E, Korr H, Schmitz C, Maier M: Extracorporeal shockwave application to the distal femur of rabbits diminishes the number of neurons immunoreactive for substance P in dorsal root ganglia L5. Brain Res 2008, 1207:96-101.
• [35]Schmitz C, DePace R: Pain relief by extracorporeal shockwave therapy: an update on the current understanding. Urol Res 2009, 37:231-234.
• [36]Klonschinski T, Ament SJ, Schlereth T, Rompe JD, Birklein F: Application of local anesthesia inhibits effects of low-energy extracorporeal shock wave treatment (ESWT) on nociceptors. Pain Med 2011, 12:1532-1537.
• [37]Michelson J: Study of plantar fasciitis treatment is flawed. Brit Med J 2003, 327:870.
• [38]Liden B, Simmons M, Landsman AS: A retrospective analysis of 22 patients treated with percutaneous radiofrequency nerve ablation for prolonged moderate to severe heel pain associated with plantar fasciitis. J Foot Ankle Surg 2009, 48:642-647.
• [39]Hormozi J, Lee S, Hong DK: Minimal invasive percutaneous bipolar radiofrequency for plantar fasciotomy: a retrospective study. J Foot Ankle Surg 2011, 50:283-286.
• [40]Sorensen MD, Hyer CF, Philbin TM: Percutaneous bipolar radiofrequency microdebridement for recalcitrant proximal plantar fasciosis. J Foot Ankle Surg 2011, 50:165-170.
• [41]Landsman AS, Catanese DJ, Wiener SN, Richie DH Jr, Hanft JR: A prospective, randomized, double-blinded study with crossover to determine the efficacy of radio-frequency nerve ablation for the treatment of heel pain. J Am Podiatr Med Assoc 2013, 103:8-15.
• [42]Tay KS, Ng YC, Singh IR, Chong KW: Open technique is more effective than percutaneous technique for TOPAZ radiofrequency coblation for plantar fasciitis. Foot Ankle Surg 2012, 18:287-292.
• [43]FDA Pre-Market Approval (PMA) of the Orthospec device http://www.accessdata.fda.gov/cdrh_docs/pdf4/P040026b.pdf webcite
• [44]Schelling G, Delius M, Gschwender M, Grafe P, Gambihler S: Extracorporeal shock waves stimulate frog sciatic nerves indirectly via a cavitation-mediated mechanism. Biophys J 1994, 66:133-140.